Predictive value of P‑selectin and endothelin‑1 for vascular restenosis after interventional procedures for peripheral artery disease

Chen,Nan; Chen,Linwei; Jiang,Su; Wang,Zichuan; Liu,Tao

doi:10.3892/etm.2019.7407

Predictive value of P‑selectin and endothelin‑1 for vascular restenosis after interventional procedures for peripheral artery disease

Authors:
- Nan Chen
- Linwei Chen
- Su Jiang
- Zichuan Wang
- Tao Liu
View Affiliations

Affiliations: Department of Science of Epidemic Febrile Disease, School of Basic Medical Sciences, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
Published online on: March 18, 2019 https://doi.org/10.3892/etm.2019.7407
Pages: 3907-3912
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Peripheral artery disease (PAD) is caused by the building up of plaques in the arteries that carry blood to the lower limbs. The present study aimed to assess the predictive value of the plasma levels of P‑selectin (Ps) or endothelin‑1 (ET‑1) regarding the occurrence of vascular restenosis after endovascular therapy for PAD. Patients with or without vascular restenosis confirmed by computed tomography angiography after endovascular therapy between March and December 2015 (n=20 per group) were enrolled. The serum levels of Ps and ET‑1 prior to the operation and at 1 h, as well as 1, 2 and 3 weeks after the operation were compared between the two groups. At 1 h after the operation, the serum levels of Ps and ET‑1 were significantly increased as compared with the pre‑operative levels (P<0.05). The serum levels of Ps and ET‑1 at 1 h, as well as 1, 2 and 3 weeks after the operation in the restenosis group were significantly higher as compared with those in the non‑stenosis group (P<0.05). However, for the non‑stenosis group, the serum levels of Ps and ET‑1 at 1, 2 and 3 weeks after the operation did not significantly differ from the pre‑operative levels (P>0.05). The diagnostic sensitivity and specificity of the serum ET‑1 levels at 1 h after the operation for predicting post‑operative restenosis in PAD patients with a cut‑off of 0.1089 pg/ml were 85 and 85%, respectively. In conclusion, the serum levels of Ps and ET‑1 have a high predictive value for post‑operative vascular restenosis after endovascular therapy for PAD patients.

View Figures

View References

1	Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS and Murad MH: A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 61 Suppl 3:S42–S53. 2015. View Article : Google Scholar
2	Criqui MH and Aboyans V: Epidemiology of peripheral artery disease. Circ Res. 116:1509–1526. 2015. View Article : Google Scholar : PubMed/NCBI
3	Lin TY, Yang FC, Lin CL, Kao CH, Lo HY and Yang TY: Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study. Medicine (Baltimore). 95:e44802016. View Article : Google Scholar : PubMed/NCBI
4	Baerlocher MO, Kennedy SA, Rajebi MR, Baerlocher FJ, Misra S, Liu D and Nikolic B: Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease. J Vasc Interv Radiol. 26:459–473. 2015. View Article : Google Scholar : PubMed/NCBI
5	Kumada Y, Aoyama T, Ishii H, Tanaka M, Kawamura Y, Takahashi H, Toriyama T, Aoyama T, Yuzawa Y, Maruyama S, et al: Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant. 23:3996–4001. 2008. View Article : Google Scholar : PubMed/NCBI
6	Koskinas KC, Chatzizisis YS, Antoniadis AP and Giannoglou GD: Role of endothelial shear stress in stent restenosis and thrombosis: Pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol. 59:1337–1349. 2012. View Article : Google Scholar : PubMed/NCBI
7	Wilson WR, Fitridge RA, Weekes AJ, Morgan C, Tavella R and Beltrame JF: Quality of life of patients with peripheral arterial disease and chronic stable angina. Angiology. 63:223–228. 2012. View Article : Google Scholar : PubMed/NCBI
8	Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T and Ichikawa S: 15-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv. 8:1893–1901. 2015. View Article : Google Scholar : PubMed/NCBI
9	Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N and Embury SH: A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 87:536–539. 2012. View Article : Google Scholar : PubMed/NCBI
10	Abraham D and Distler O: How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther. 9 Suppl 2:S22007. View Article : Google Scholar : PubMed/NCBI
11	Michel JB, Li Z and Lacolley P: Smooth muscle cells and vascular diseases. Cardiovasc Res. 95:135–137. 2012. View Article : Google Scholar : PubMed/NCBI
12	Gu P, Theiss A, Han J and Feagins LA: Increased cell adhesion molecules, PECAM-1, ICAM-3, or VCAM-1, predict increased risk for flare in patients with quiescent inflammatory bowel disease. J Clin Gastroenterol. 51:522–527. 2017. View Article : Google Scholar : PubMed/NCBI
13	Thomas MR, Wijeyeratne YD, May JA, Johnson A, Heptinstall S and Fox SC: A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel. Platelets. 25:612–618. 2014. View Article : Google Scholar : PubMed/NCBI
14	Myers DD Jr, Henke PK, Bedard PW, Wrobleski SK, Kaila N, Shaw G, Meier TR, Hawley AE, Schaub RG and Wakefield TW: Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg. 44:625–632. 2006. View Article : Google Scholar : PubMed/NCBI
15	Pabinger I and Ay C: Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol. 29:332–336. 2009. View Article : Google Scholar : PubMed/NCBI
16	Geng JG, Chen M and Chou KC: P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem. 11:2153–2160. 2004. View Article : Google Scholar : PubMed/NCBI
17	Panicker SR, Mehta-D'souza P, Zhang N, Klopocki AG, Shao B and Mcever RP: Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice. Blood. 130:181–191. 2017. View Article : Google Scholar : PubMed/NCBI
18	Pabinger I and Ay C: Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol. 29:332–336. 2009. View Article : Google Scholar : PubMed/NCBI
19	Biasin V, Chwalek K, Wilhelm J, Best J, Marsh LM, Ghanim B, Klepetko W, Fink L, Schermuly RT, Weissmann N, et al: Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent. Int J Biochem Cell Biol. 54:137–148. 2014. View Article : Google Scholar : PubMed/NCBI
20	Jiang HN, Zeng B, Chen GL, Lai B, Lu SH and Qu JM: Lipopolysaccharide potentiates endothelin-1-induced proliferation of pulmonary arterial smooth muscle cells by upregulating TRPC channels. Biomed Pharmacother. 82:20–27. 2016. View Article : Google Scholar : PubMed/NCBI
21	Meoli DF and White RJ: Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase. Can J Physiol Pharmacol. 88:830–839. 2010. View Article : Google Scholar : PubMed/NCBI
22	Romano F, Gambara G, De Cesaris P, Ziparo E, Palombi F and Filippini A: Endothelin induces functional hypertrophy of peritubular smooth muscle cells. J Cell Physiol. 212:264–273. 2007. View Article : Google Scholar : PubMed/NCBI